RDHL RedHill Biopharma ADRs

RedHill Biopharma Ltd is a specialty biopharmaceutical company engaged in the development and commercialization of late clinical-stage, proprietary, and small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer. This is an ADR of a company whose stock trades outside of the U.S. as the symbol IT:RDHL.

$0.96  -0.06 (-6.19%)
As of 05/24/2022 15:40:15 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Israel
Country of incorporation:  Israel
IPO date:  02/11/2013
Outstanding shares:  52,684,229
Average volume:  383,832
Market cap:   $54,264,756
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      B96DLZ7
Valuation   (See tab for details)
PE ratio:   -0.55
PB ratio:   6.07
PS ratio:   0.63
Return on equity:   -1,101.34%
Net income %:   -113.98%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy